comparemela.com

Latest Breaking News On - Non alcoholic steato hepatitis - Page 3 : comparemela.com

Lupin to co-market Zydus liver disease drug Saroglitazar Mg in India

Lupin to co-market Zydus liver disease drug Saroglitazar Mg in India
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Sharvil patelZydus lifesciencesNilesh guptaLupin ltdNon alcoholic fatty liver diseaseNon alcoholic steato hepatitisLupin managing directorZydus managing directorAlcoholic liver disease

Zydus, Lupin enter licensing pact to market drug to treat liver disease

Zydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing fees and milestone payments based on the achievement of pre-defined milestones. With a once-daily, 4mg dose regimen, Saroglitazar Mg enables better compliance, reduces pill burden, and offers greater convenience for patients.

Sharvil patelSun pharmaZydus lifesciencesNilesh guptaNon alcoholic fatty liver diseaseNon alcoholic steato hepatitisDiabetes mellitusMarket drugTreat liverTreat diseaseLiver disease

Lupin to co-market Zydus liver disease drug Saroglitazar Mg in India

Lupin to co-market Zydus liver disease drug Saroglitazar Mg in India
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Sharvil patelZydus lifesciencesNilesh guptaLupin ltdNon alcoholic fatty liver diseaseNon alcoholic steato hepatitisLupin managing directorZydus managing directorAlcoholic liver disease

Ferring tool tracks antibiotic effect on gut microbiota

A prototype biomarker that recognises antibiotic-induced gut dysbiosis has been created by a team from Ferring Pharmaceuticals, who believe the tool could help in developing future biotherapeutics.

Kristin wannerbergerKen blountMicrobiome health indexFrench national research institute for agricultureMicrobiome research at rebiotixChief scientific officerVice presidentMicrobiome researchIrritable bowel syndromeSeres therapeuticsFrench national research instituteNon alcoholic fatty liver diseaseNon alcoholic steato hepatitisNovel microbiome based biomarkerPost antibiotic dysbiosisSubsequent restoration

Ferring tool tracks antibiotic effect on gut microbiota

A prototype biomarker that recognises antibiotic-induced gut dysbiosis has been created by a team from Ferring Pharmaceuticals, who believe the tool could help in developing future biotherapeutics.

Kristin wannerbergerKen blountMicrobiome health indexFrench national research institute for agricultureMicrobiome research at rebiotixChief scientific officerVice presidentMicrobiome researchIrritable bowel syndromeSeres therapeuticsFrench national research instituteNon alcoholic fatty liver diseaseNon alcoholic steato hepatitisNovel microbiome based biomarkerPost antibiotic dysbiosisSubsequent restoration

vimarsana © 2020. All Rights Reserved.